133 related articles for article (PubMed ID: 22741468)
1. [Inhibitory effects of astragaloside IV on cytochrome P450 enzyme of rat liver microsomes].
Shan W; Zhang Y; Zhu J; Shao Q; Fan X
Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):85-8. PubMed ID: 22741468
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV inhibited the activity of CYP1A2 in liver microsomes and influenced theophylline pharmacokinetics in rats.
Zhang YH; Zhang YJ; Guo YL; Li WJ; Yu C
J Pharm Pharmacol; 2013 Jan; 65(1):149-55. PubMed ID: 23215698
[TBL] [Abstract][Full Text] [Related]
3. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
Eagling VA; Tjia JF; Back DJ
Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of cytochrome P450 enzymes CYP1A2, CYP2A6, CYP2E1 and CYP3A4 by extracts and alkaloids of Gelsemium elegans roots.
Wang Y; Wu S; Chen Z; Zhang H; Zhao W
J Ethnopharmacol; 2015 May; 166():66-73. PubMed ID: 25764964
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of seven components of danshen extract on catalytic activity of cytochrome P450 enzyme in human liver microsomes.
Qiu F; Zhang R; Sun J; Jiye A; Hao H; Peng Y; Ai H; Wang G
Drug Metab Dispos; 2008 Jul; 36(7):1308-14. PubMed ID: 18411400
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.
Bourrié M; Meunier V; Berger Y; Fabre G
J Pharmacol Exp Ther; 1996 Apr; 277(1):321-32. PubMed ID: 8613937
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive assay for nine major cytochrome P450 enzymes activities with 16 probe reactions on human liver microsomes by a single LC/MS/MS run to support reliable in vitro inhibitory drug-drug interaction evaluation.
Peng Y; Wu H; Zhang X; Zhang F; Qi H; Zhong Y; Wang Y; Sang H; Wang G; Sun J
Xenobiotica; 2015; 45(11):961-77. PubMed ID: 26007223
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
Draper AJ; Madan A; Parkinson A
Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase.
Grimm SW; Dyroff MC
Drug Metab Dispos; 1997 May; 25(5):598-602. PubMed ID: 9152599
[TBL] [Abstract][Full Text] [Related]
10. In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.
Taavitsainen P; Juvonen R; Pelkonen O
Drug Metab Dispos; 2001 Mar; 29(3):217-22. PubMed ID: 11181487
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of imperatorin and isoimperatorin on activity of cytochrome P450 enzyme in human and rat liver microsomes].
Cao Y; Zhong YH; Yuan M; Li H; Zhao CJ
Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(8):1237-41. PubMed ID: 23944042
[TBL] [Abstract][Full Text] [Related]
12. [Interaction between four herb compounds and a western drug by CYP3A4 enzyme metabolism in vitro].
Shen G; Liang A; Zhao Y; Cao C; Liu T; Li C; Nilsen OG
Zhongguo Zhong Yao Za Zhi; 2009 Jul; 34(13):1705-11. PubMed ID: 19873787
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of curcumin on activity of cytochrome P450 2C9 enzyme in human and 2C11 in rat liver microsomes.
Wang Z; Sun W; Huang CK; Wang L; Xia MM; Cui X; Hu GX; Wang ZS
Drug Dev Ind Pharm; 2015 Apr; 41(4):613-6. PubMed ID: 24517573
[TBL] [Abstract][Full Text] [Related]
14. Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms.
Or PM; Lam FF; Kwan YW; Cho CH; Lau CP; Yu H; Lin G; Lau CB; Fung KP; Leung PC; Yeung JH
Phytomedicine; 2012 Apr; 19(6):535-44. PubMed ID: 22261394
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of Hwang-Ryun-Hae-Dok-Tang on cytochrome P450 in human liver microsomes.
Lee SY; Jang H; Lee JY; Ma JY; Oh SJ; Kim SK
Xenobiotica; 2015 Feb; 45(2):131-8. PubMed ID: 25145883
[TBL] [Abstract][Full Text] [Related]
16. In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes.
Wei J; Zhang H; Zhao Q
Pharm Biol; 2018 Dec; 56(1):363-367. PubMed ID: 30122094
[TBL] [Abstract][Full Text] [Related]
17. [In vitro inhibitory effects of Jiawei Foshou San capsule on activity of cytochrome P450 enzymes in rat and human liver microsomes].
Shang FH; Feng S; Chen Q; Chen XJ; Zhang JF; Xu XY
Yao Xue Xue Bao; 2016 Jun; 51(6):926-30. PubMed ID: 29879346
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
Mössner LD; Schmitz A; Theurillat R; Thormann W; Mevissen M
Am J Vet Res; 2011 Nov; 72(11):1505-13. PubMed ID: 22023129
[TBL] [Abstract][Full Text] [Related]
19. Fondaparinux sodium is not metabolised in mammalian liver fractions and does not inhibit cytochrome P450-mediated metabolism of concomitant drugs.
Lieu C; Shi J; Donat F; Van Horn R; Brian W; Newton J; Delbressine L; Vos R
Clin Pharmacokinet; 2002; 41 Suppl 2():19-26. PubMed ID: 12383041
[TBL] [Abstract][Full Text] [Related]
20. Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions.
Lee KS; Kim SK
J Appl Toxicol; 2013 Feb; 33(2):100-8. PubMed ID: 21915887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
